
Medically Reviewed By
Dr. Deepak Garg ( Orthopaedic Oncology & Robotic Joint Surgery)
A pediatric and young adult orthopaedic oncology treatise on Ewing Sarcoma of bone and soft tissues, exploring the EWSR1-FLI1 genetic translocation, intensive neoadjuvant chemotherapy (VIDE / VDC-IE), computer-navigated wide resection, modular megaprosthesis reconstruction, and adjuvant radiation.
CRITICAL CLINICAL RED FLAG: A young child or teenager presenting with persistent, deep, localized bone pain (often worse at night) and a tender, warm, expanding soft tissue mass resembling osteomyelitis must undergo urgent plain radiography and contrast MRI before any surgical drainage is attempted.
Ewing Sarcoma is a highly malignant Small Round Blue Cell Tumor characterized in >85% of cases by the non-random reciprocal chromosomal translocation t(11;22)(q24;q12), generating the aberrant EWSR1-FLI1 chimeric oncoprotein. It predominantly affects children, adolescents, and young adults (ages 5 to 25) with a predilection for the diaphysis of long bones and the pelvis.
Onion-Skin Periosteal Reaction: Multi-layered subperiosteal new bone formation on plain radiographs.
Massive Soft Tissue Component: The extraosseous soft tissue mass is often significantly larger than the intraosseous bone lesion.
Mandatory Core Needle Biopsy: Verified by CD99 (MIC2) diffuse membranous positivity and EWSR1 rearrangement on FISH or RT-PCR.
Systemic chemotherapy is administered upfront to eradicate microscopic micrometastases and shrink the soft tissue mass:
VIDE Protocol: 6 cycles of Vincristine, Ifosfamide (with Mesna uroprotection), Doxorubicin, and Etoposide administered every 21 days with G-CSF support.
Interval-Compressed VDC/IE: Alternative regimen delivering Vincristine-Doxorubicin-Cyclophosphamide alternating with Ifosfamide-Etoposide every 14 days.
Restaging MRI: Assesses volumetric tumor necrosis (>90% necrosis indicates excellent histological response).
"Integrating intensive interval-compressed multi-agent chemotherapy with precise 3D navigated surgical tumor clearance achieves 5-year survival rates exceeding 75% while preserving natural limbs in over 95% of cases." — Dr. Deepak Garg

Following neoadjuvant chemotherapy, wide en-bloc margin clearance is performed. For growing pediatric patients, custom modular expandable megaprostheses can be lengthened non-invasively using an external magnetic field without additional surgery.
CLINICAL CAUTION: Incision and drainage of a suspected Ewing Sarcoma misdiagnosed as an abscess contaminates anatomical tissue planes and drastically jeopardizes the chance of saving the limb.
Adjuvant radiotherapy (45–54 Gy) is utilized for close surgical margins, pelvic primary sites, or poor histological responders to ensure long-term locoregional control.
1. Results of the Euro-EWING99 trial: VIDE chemotherapy for localized and metastatic Ewing sarcoma — J Clin Oncol, 2020; 38(34): 3998-4007.
2. Limb-salvage surgery and reconstruction with modular prostheses in pediatric Ewing sarcoma — Bone Joint J, 2021; 103-B(9): 1560-1570.

Senior Consultant & Clinical Director — Orthopaedic Oncology & Robotic Joint Surgery
MBBS (TNMC Mumbai), DNB Orthopaedics (PGI & SP Miraj), Fellowship Arthroplasty and Arthroscopy (Fortis Hospital, New Delhi), Fellowship Orthopaedic Oncology (Rajiv Gandhi Cancer Institute, New Delhi)

16+ Years Experience
Spica — Grover Hospital
Request a priority OPD appointment or second opinion on your scans.
Proprietary surgical methodologies and precision protocols pioneered by our senior directors to minimize trauma, protect natural anatomy, and accelerate recovery.

Dr. Deepak Garg (Orthopaedic Surgical Oncology - RGCI Delhi Trained) and Dr. Neha Gupta (Medical Oncology) co-lead the Bone Cancer & Sarcoma Center at Spica Healthcare. Integrating intensive multi-agent neoadjuvant chemotherapy protocols (MAP: High-Dose Methotrexate, Doxorubicin, Cisplatin for Osteosarcoma; VIDE: Vincristine, Ifosfamide, Doxorubicin, Etoposide for Ewing Sarcoma) with 3D computer-navigated limb salvage surgery and modular titanium megaprosthetic joint reconstruction, 5-year survival rates exceed 75% to 80% while saving over 95% of patients from limb amputation.
Spica Healthcare — Bone and Cancer Institute, Bathinda — is South-Western Punjab's premier super-speciality centre led by AIIMS and Tata Memorial fellowship-trained directors.
Every diagnostic MRI review, surgical staging, and operation is personally directed by chief clinical specialists — Dr. Deepak Garg (Orthopaedic Oncology & Robotics) and Dr. Neha Gupta (Medical Oncology) — guaranteeing zero junior proxies.
Sub-millimeter implant positioning and soft-tissue ligament balancing ensuring patients walk comfortably within 24 hours of total knee replacement.
South-West Punjab's only dedicated centre for modular titanium megaprosthesis, saving natural limbs and functions in 95%+ of bone cancer patients.
Full cashless coverage for Ayushman Bharat (PM-JAY), Punjab Govt Health Schemes, ECHS, and 30+ private insurance networks with on-desk approvals.
Positive-pressure HEPA filtered theatres minimizing infection rates below international benchmarks with 24/7 dedicated critical care backup.
Fellowship-trained surgical directors from AIIMS & Tata Memorial providing compassionate, world-class tertiary care in super-speciality orthopaedics and medical oncology.

Senior Consultant & Clinical Director — Medical Oncology
MBBS (BFUHS Faridkot), MD Radiation Oncology (BFUHS Faridkot), DrNB Medical Oncology (Sarvodaya Hospital, Faridabad), Precision Oncology (Harvard, USA), Ex Consultant RGCI New Delhi


Senior Consultant & Clinical Director — Orthopaedic Oncology & Robotic Joint Surgery
16+ Yrs ExpSenior Consultant & Clinical Director — Orthopaedic Oncology & Robotic Joint Surgery
MBBS (TNMC Mumbai), DNB Orthopaedics (PGI & SP Miraj), Fellowship Arthroplasty and Arthroscopy (Fortis Hospital, New Delhi), Fellowship Orthopaedic Oncology (Rajiv Gandhi Cancer Institute, New Delhi)
Free OPD screening camps, director-led masterclasses, and national oncology representations by Spica Healthcare.
Real stories from patients who recovered through limb preservation surgery, 3D robotic joint replacements, and precision cancer care at Spica Healthcare — Grover Hospital, Bathinda.
Evidence-based surgical recovery roadmaps, robotic joint protocols, and precision oncology insights written by our clinical directors.